Major 10% Investor, The Column Group, Sells $2.89M in Shares

summarizeSummary

The Column Group, a 10% owner, reported selling approximately $2.89 million worth of Tenaya Therapeutics shares in a series of transactions from February 20-25, reducing their beneficial ownership to 23.1%.

check_boxKey Events

• Significant Share Disposition

  The Column Group, a major institutional investor, sold approximately $2.89 million worth of common stock through multiple transactions between February 20 and February 25, 2026.

• Reduced Ownership Stake

  Following these sales, The Column Group's beneficial ownership in Tenaya Therapeutics has decreased to 23.1% of the outstanding common stock.

• Confirmation of Prior Intent

  These executed sales confirm the intent to sell previously indicated by Form 144 filings from The Column Group entities on February 20 and February 25, 2026.

auto_awesomeAnalysis

This Schedule 13D/A confirms significant selling activity by The Column Group, a major institutional investor in Tenaya Therapeutics. The sales, totaling approximately $2.89 million, occurred over several days in late February and represent a substantial reduction in their stake. This follows recent Form 144 filings that indicated an intent to sell, now executed. Such a large disposition by a key investor could signal a loss of confidence or a strategic portfolio rebalancing, potentially creating an overhang on the stock.